Iris W.J.M. van Goor

Author

Also Known As

I. W. J. M. van Goor, I.W.J.M. van Goor, Iris W.J.M. van Goor, Iris W J M van Goor, Iris W. J. M. van Goor, Iris W.J.M. van Goor, Iris van Goor

Publications

130

Citations

H-Index

Concepts

All Affiliations

Iris W.J.M. van Goor is an author at University Medical Center Utrecht specializing in surgical oncology, gastroenterology, and surgery.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	14
2	Gastroenterology	1	1	14
3	Pathology	1	1	14
4	Surgical Oncology	1	1	14
5	Surgery	1	1	14

Iris W.J.M. van Goor

Publications

Citations

H-Index

Page 1

	Year	Citations
Impact of complications after resection of pancreatic cancer on disease recurrence and survival, and mediation effect of adjuvant chemotherapy: nationwide, observational cohort study Anne Claire Henry, Jelle C. van Dongen, Iris W.J.M. van Goor, BJS Open	2023	27
Predicting Long-term Disease-free Survival After Resection of Pancreatic Ductal Adenocarcinoma Iris W.J.M. van Goor, Thijs J. Schouten, Daphne N. Verburg, Annals of Surgery	2023	22
Microscopic resection margin status in pancreatic ductal adenocarcinoma – A nationwide analysis Lois A. Daamen, Iris W.J.M. van Goor, Thijs J. Schouten, European Journal of Surgical Oncology Surgical OncologyPancreatic CancerA Nationwide AnalysisGastroenterologyPathology	2020	14
The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection: A Nationwide Analysis Thijs J. Schouten, Iris W.J.M. van Goor, Galina Dorland, Annals of Surgical Oncology	2024	12
Predicting post-recurrence survival for patients with pancreatic cancer recurrence after primary resection: A Bi-institutional validated risk classification A. Floortje van Oosten, Lois A. Daamen, Vincent P. Groot, European Journal of Surgical Oncology	2023	11
A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE) Iris W.J.M. van Goor, Lois A. Daamen, Marc G. Besselink, Trials	2022	10

Page 1